fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether and Bilirubinemia

fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether has been researched along with Bilirubinemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akhteruzzaman, S; Hisaka, A; Kato, Y; Sugiyama, Y	1

Other Studies

1 other study(ies) available for fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether and Bilirubinemia

Article	Year
Primary active transport of peptidic endothelin antagonists by rat hepatic canalicular membrane. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 288, Issue:2 Topics: Adenosine Triphosphate; Animals; Anion Transport Proteins; Azepines; Bile Canaliculi; Biological Transport, Active; Carrier Proteins; Drug Interactions; Endothelin Receptor Antagonists; Ethers; Hydrocarbons, Fluorinated; Hyperbilirubinemia; Kinetics; Liver; Male; Membranes; Oligopeptides; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Tritium	1999

Article

Year

Primary active transport of peptidic endothelin antagonists by rat hepatic canalicular membrane.

The Journal of pharmacology and experimental therapeutics, 1999, Volume: 288, Issue:2

Topics: Adenosine Triphosphate; Animals; Anion Transport Proteins; Azepines; Bile Canaliculi; Biological Transport, Active; Carrier Proteins; Drug Interactions; Endothelin Receptor Antagonists; Ethers; Hydrocarbons, Fluorinated; Hyperbilirubinemia; Kinetics; Liver; Male; Membranes; Oligopeptides; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Tritium

1999